Cell and Gene Therapy, SAB August 17, 2023 RoslinCT Announces the Appointment of Dr. Derek Hei to its Scientific Advisory Board
Cell Therapy, cGMP Manufacturing June 05, 2023 RoslinCT and Lykan Bioscience Announce Integration to Establish Global Advanced Cell and Gene Therapy CDMO Service Offerings
Cell and Gene Therapy, Integration May 30, 2023 RoslinCT and Lykan Bioscience announce that the MHRA has granted an MIA License for their cGMP Manufacturing facilities in Edinburgh, UK
Cell Therapy April 20, 2023 Life Sciences in Scotland: How Edinburgh Technopole is Driving Innovation
Leadership, New cGMP suites, Partnerships, Site Expansion February 23, 2023 RoslinCT and Lykan Bioscience Announce the Addition of Six cGMP Suites to Meet Growing Demand
Leadership, Partnerships, Scientific Advisor January 10, 2023 RoslinCT and Lykan Bioscience Announce the Appointment of Dr. Michael Mendicino to its Scientific Advisory Board
Leadership September 19, 2022 RoslinCT Boston (former Lykan Bioscience) Appoints Barbara Ressler, Ph.D. as Vice President, Manufacturing Process Sciences
Leadership, Partnerships September 12, 2022 RoslinCT and Lykan Bioscience Announce the Establishment of a Scientific Advisory Board
Leadership, Partnerships August 04, 2022 RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO